NCT01490086 - RP5063 in Subjects With Schizophrenia or Schizoaffective Disorder | Biotech Hunter

Enrollment

234

Participants

Timeline

Start Date

December 31, 2011

Primary Completion Date

March 31, 2013

Study Completion Date

March 31, 2013

Conditions

Acute SchizophreniaSchizoaffective Disorder

Interventions

DRUG

RP5063

daily

DRUG

placebo

daily

DRUG

aripiprazole

daily

Trial Locations (15)

Reviva site, Philadelphia

Reviva site, Bangalore

Reviva site, Chennai

Reviva site, Guntur

Reviva site, Jaipur

Reviva site, Kanpur

Reviva site, Lucknow

Reviva site, Mangalore

Reviva site, Johor Bahru

Reviva site, Kuala Lumpur

Reviva Site, Tanjung Rambutan

Reviva site, Chisinau

Reviva site, Mandaluyong

Reviva site, Mandurriao

Reviva site, Subandaku